PLS Reports Record Lithium Output as EV Demand Fuels Market Growth 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
Meta Expands AI Training With Employee Activity Tracking Tools 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation 
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia 
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity 
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility 
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand 
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture 
SAN CLEMENTE, Calif., March 27, 2017 -- David Steenblock, D.O., an osteopathic physician based in San Clemente, CA, uses hyperbaric oxygen to achieve significant and improved lifestyle outcomes for many stroke patients. He is one of the country’s leading practitioners in the therapeutic use of oxygen under pressure to dramatically reduce the effects of stroke and brain injury.
“Many of our cases have demonstrated a 40-100 percent rate of improvement for stroke victims who received oxygen under pressure, “ says Dr. Steenblock. He encourages U.S. physicians to consider the merits of this approach.
Dr. Steenblock treated a 62-year old patient with a stroke that completely paralyzed her right arm and left her severally bent over and limping, He prescribed his patient a series of 60 treatments--within 12 weeks--in a hyperbaric oxygen chamber. Increasing a person’s level of dissolved oxygen using HBOT can activate neuroplasticity and improve stroke-induced neurologic deficiencies, he added.
The goal is to get as much oxygen into the brain as possible. This helps to revive oxygen-starved, damaged brain tissue, Dr. Steenblock explains. This principle holds true for traumatic brain injury as well, where brain tissue is irreversibly destroyed, as brain cells deprived of oxygen usually die within 10 minutes, but a larger portion is potentially revivable.
After one month of treatment, the patient showed clear signs of improvement, with walking, posture and range of motion noticeably improved. She was able to open and close her right hand, grip and squeeze objects, and raise her arm to her chest.
Dr. David Steenblock is a leading-edge physician in many fields of medicine, from stroke care, to acute brain trauma, to generative and cell-based medicine in the treatment of ALS, Cerebral Palsy and other chronic and degenerative diseases. For more information about Dr. Steenblock’s work in stroke therapy, visit www.stemcellmd.org
Irene Doti [email protected]
